Erasca | Investor Presentation Deck | 41 slides · page 14 of 41
The chart shows lower IC50 values for the Q61X mutation group, suggesting higher sensitivity to the drug.
Pitch deck · traction · analyze_data · balanced density
Slide locked Sign in to view
Slide schematic 3/3
chart 1/1 source-note 1/1 title 1/1
Components 3
box source-note action-title
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.